Dark

FENC
Fennec Pharmaceuticals Inc. Common Stock
stock NASDAQ

Market Open

Jul 27, 2026 2:15:53 PM EDT

10.33USD+3.403%(+0.34)67,296

10.32Bid 10.40Ask 0.08Spread

Pre-market

0.00USD-100.000%(-9.99)0

After-hours

Jul 24, 2026 4:00:30 PM EDT

9.99USD+0.201%(+0.02)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

358.83M

CEO

Rostislav Raykov

Headquarters

Durham, North Carolina, USA

Industry

Biotechnology

Next Earnings

Aug 13, 2026 (17d)

Last Split

Aug 30, 20111for17.9986reverse

AMGN GSK BMY JNJ LLY PFE SNY INSY XLV

FENC Stats

Avg. Vol. 10 Day

160,304

Avg. Vol. 30 Day

234,423

Market Cap

358,833,520

Shares Out.

34,737,030

On/Off Exchange

59%/41%

6 Month Beta

1.64

1 Year Beta

1.55

2 Year Beta

1.05

3 Year Beta

0.97

52 Week Low

5.65

52 Week High

11.31

SMA50

9.86

SMA200

8.21

1 Week

+4.34%

1 Month

-6.26%

3 Month

+50.80%

6 Month

+31.59%

1 Year

+19.28%

2 Year

+58.68%

5 Year

+56.04%

Profile

fennec pharmaceuticals inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the united states. its lead product pedmark, a formulation of sodium thiosulfate, which has completed the phase iii clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. the company was formerly known as adherex technologies inc. and changed its name to fennec pharmaceuticals inc. in september 2014. fennec pharmaceuticals inc. was founded in 1996 and is based in research triangle park, north carolina.

FENC Stock Summary

Fennec Pharmaceuticals Inc. Common Stock (NASDAQ:FENC) stock price today is $10.33, and today's volume is 67,296. FENC is up 3.403% today. The 30 day average volume is 234,423. FENC market cap is 358.83M with 34,737,030 shares outstanding.